Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: June 2021

MissionIRNewsBreaks – Nextech AR Solutions Corp. (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29) Completes Acquisition of Leading AI Company

Posted on June 22, 2021 by MissionIR

Nextech AR Solutions (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), a diversified leading provider of augmented reality (“AR”) experience technologies and services, announced that it has completed the acquisition of Threedy.ai Inc. The acquisition of the artificial intelligence (“AI”) … Continue reading →

Posted in Nextech AR Solutions Corp. NEXCF | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Completes 51st Pre-Clinical Psychedelic Molecule Study

Posted on June 22, 2021 by MissionIR

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, announced that it has completed its 51st preclinical study; the study is a critical step in the company’s progress in the Investigational New Drug (“IND”) process. The … Continue reading →

Posted in Cybin Inc. CLXPF | Leave a comment

Knightscope Inc.’s Growing Client Base and its Quest to Make the United States the Safest Nation in the World

Posted on June 21, 2021 by MissionIR

Knightscope Inc. has seen a 46% drop in reported crime at one location and has operated over 1,000,000 hours of service for its autonomous security robots nationwide The versatility of the robots have seen their deployment in various areas such … Continue reading →

Posted in Knightscope, Inc. | Leave a comment

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Gains Inclusion on Russell 2000 Index as Brain Cancer Trial Enrollment Advances

Posted on June 21, 2021 by MissionIR

Brain cancer drug developer CNS Pharmaceuticals is actively enrolling patients for a potentially pivotal Phase 2 trial of the company’s lead drug candidate, Berubicin, a promising candidate for treating a devastating condition CNS’s focus has been on developing a means … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Save Foods Inc. (NASDAQ: SVFD) Is ‘One to Watch’

Posted on June 21, 2021 by MissionIR

The agricultural produce treatment space has been active in recent years, attracting more than $26 billion in new investment in 2020 In May 2021, Save Foods Inc. closed on a $12 million public offering and uplisted its shares to the … Continue reading →

Posted in Save Foods Inc. SVFD | Leave a comment

Brain Scientific Inc. (BRSF) Pediatric-Specific Disposable EEG Cap Now Available

Posted on June 21, 2021 by MissionIR

The company has developed and brought to market a pediatric NeuroCap  EEG testing in pediatrics may help diagnose autism, one of the fastest-growing developmental disorders in the US, and provide better treatment for pediatric patients with epilepsy  COVID-19 made the … Continue reading →

Posted in Brain Scientific Inc. BRSF | Leave a comment

MissionIRNewsBreaks – Brain Scientific Inc. (BRSF) Revolutionizing Portable EEG Diagnostics Space

Posted on June 21, 2021 by MissionIR

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, has created powerful yet affordable solutions that bring brain diagnostics to settings where it was previously impossible or difficult to conduct neurological testing. Concussions resulting from head trauma in … Continue reading →

Posted in Brain Scientific Inc. BRSF | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Participate at the Emerging Growth Conference

Posted on June 21, 2021 by MissionIR

Cybin (NEO: CYBN) (OTCQB: CLXPF) has announced that its CEO Doug Drysdale will be participating at the 2021 Emerging Growth Conference, which is scheduled for June 23, 2021.As part of his participation, Drysdale will be presenting a live webcast featuring … Continue reading →

Posted in Cybin Inc. CLXPF | Leave a comment

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Reports First Quarter Financials; Anticipates Improved Patient Outcomes with Berubicin

Posted on June 18, 2021 by MissionIR

Company expects reporting on interim analysis for the first 18 patients of a Phase 2 multicenter clinical trial of Berubicin in adult GBM patients during the first half of 2022 One patient from the first Berubicin trial has survived cancer-free … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Infobird Co., Ltd (NASDAQ: IFBD) Agreements with Zu Li Jian, SaSa Cosmetics, Show Emerging Respect for Its Unique SaaS Solutions

Posted on June 18, 2021 by MissionIR

AI solutions company Infobird has announced an agreement to provide e-commerce platform upgrades for elderly consumer footwear manufacturing giant Zu Li Jian The Beijing-based company delivers intelligent B2B services, and the Zu Li Jian agreement demonstrates the growing integration of … Continue reading →

Posted in Infobird Software Co. Ltd. IFBD | Leave a comment